Biosurgical Agents | Market Insights | Japan | 2024
The Japanese biosurgical agent market will exhibit moderate growth over the forecast period. Growth over the forecast period will be driven by continuing growth of procedures in which in biosurgical agents are used, rising awareness of the clinical benefits of these products on surgical outcomes, and the expanded indications in multiple procedures.
This Medtech 360 Report provides comprehensive data and analysis on the state of the biosurgical agent market in Japan from 2019 through 2032.